Xeris Biopharma Holdings (XERS) Change in Inventory (2020 - 2026)

Xeris Biopharma Holdings has reported Change in Inventory for 7 years, with the latest figure at -$851000.0 in Q1 2026.

• For the quarter ending Q1 2026, Change in Inventory fell 123.53% year-over-year to -$851000.0; the trailing twelve-month figure through Mar 2026 stood at $14.8 million (up 47.19% YoY), and the FY2025 full-year result was $19.3 million, up 119.61% from the prior year.
• Change in Inventory for Q1 2026 stood at -$851000.0, down from $4.0 million in the prior quarter.
• The five-year high for Change in Inventory was $7.6 million in Q2 2025, with the low at -$851000.0 in Q1 2026.
• Historically, Change in Inventory has averaged $2.9 million across 5 years, with a median of $2.3 million in 2024.
• Annual changes were most pronounced in 2023 — Change in Inventory jumped 4922.3% — and 2026, when it sank 123.53%.
• Xeris Biopharma Holdings' Change in Inventory stood at $5.5 million in 2022, then tumbled by 74.55% to $1.4 million in 2023, then surged by 123.91% to $3.1 million in 2024, then grew by 27.86% to $4.0 million in 2025, then tumbled by 121.22% to -$851000.0 in 2026.
• The last three Change in Inventory figures came in at -$851000.0 (Q1 2026), $4.0 million (Q4 2025), and $4.1 million (Q3 2025), per Business Quant data.